PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
OKE vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between OKE and PFE is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

OKE vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ONEOK, Inc. (OKE) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

-10.00%0.00%10.00%20.00%30.00%40.00%AugustSeptemberOctoberNovemberDecember2025
28.01%
-10.08%
OKE
PFE

Key characteristics

Sharpe Ratio

OKE:

2.77

PFE:

-0.13

Sortino Ratio

OKE:

3.40

PFE:

-0.03

Omega Ratio

OKE:

1.48

PFE:

1.00

Calmar Ratio

OKE:

3.55

PFE:

-0.06

Martin Ratio

OKE:

12.89

PFE:

-0.36

Ulcer Index

OKE:

4.56%

PFE:

8.60%

Daily Std Dev

OKE:

21.22%

PFE:

22.95%

Max Drawdown

OKE:

-80.17%

PFE:

-54.82%

Current Drawdown

OKE:

-8.69%

PFE:

-50.97%

Fundamentals

Market Cap

OKE:

$62.31B

PFE:

$148.59B

EPS

OKE:

$4.72

PFE:

$0.75

PE Ratio

OKE:

22.64

PFE:

34.96

PEG Ratio

OKE:

2.75

PFE:

0.20

Total Revenue (TTM)

OKE:

$14.70B

PFE:

$45.86B

Gross Profit (TTM)

OKE:

$4.12B

PFE:

$29.87B

EBITDA (TTM)

OKE:

$4.32B

PFE:

$15.61B

Returns By Period

In the year-to-date period, OKE achieves a 6.45% return, which is significantly higher than PFE's -1.17% return. Over the past 10 years, OKE has outperformed PFE with an annualized return of 16.77%, while PFE has yielded a comparatively lower 2.28% annualized return.


OKE

YTD

6.45%

1M

3.92%

6M

28.01%

1Y

61.21%

5Y*

14.54%

10Y*

16.77%

PFE

YTD

-1.17%

1M

3.84%

6M

-10.08%

1Y

-1.76%

5Y*

-3.29%

10Y*

2.28%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

OKE vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OKE
The Risk-Adjusted Performance Rank of OKE is 9595
Overall Rank
The Sharpe Ratio Rank of OKE is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of OKE is 9494
Sortino Ratio Rank
The Omega Ratio Rank of OKE is 9595
Omega Ratio Rank
The Calmar Ratio Rank of OKE is 9696
Calmar Ratio Rank
The Martin Ratio Rank of OKE is 9595
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 3939
Overall Rank
The Sharpe Ratio Rank of PFE is 4141
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 3434
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 3333
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 4444
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 4242
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

OKE vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ONEOK, Inc. (OKE) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for OKE, currently valued at 2.77, compared to the broader market-2.000.002.002.77-0.13
The chart of Sortino ratio for OKE, currently valued at 3.40, compared to the broader market-4.00-2.000.002.004.003.40-0.03
The chart of Omega ratio for OKE, currently valued at 1.48, compared to the broader market0.501.001.502.001.481.00
The chart of Calmar ratio for OKE, currently valued at 3.55, compared to the broader market0.002.004.006.003.55-0.06
The chart of Martin ratio for OKE, currently valued at 12.89, compared to the broader market-30.00-20.00-10.000.0010.0020.0012.89-0.36
OKE
PFE

The current OKE Sharpe Ratio is 2.77, which is higher than the PFE Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of OKE and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
2.77
-0.13
OKE
PFE

Dividends

OKE vs. PFE - Dividend Comparison

OKE's dividend yield for the trailing twelve months is around 3.71%, less than PFE's 6.41% yield.


TTM20242023202220212020201920182017201620152014
OKE
ONEOK, Inc.
3.71%3.94%5.44%5.69%6.36%9.74%4.68%6.01%5.09%4.28%9.85%4.27%
PFE
Pfizer Inc.
6.41%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.54%3.70%3.48%3.34%

Drawdowns

OKE vs. PFE - Drawdown Comparison

The maximum OKE drawdown since its inception was -80.17%, which is greater than PFE's maximum drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for OKE and PFE. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-8.69%
-50.97%
OKE
PFE

Volatility

OKE vs. PFE - Volatility Comparison

ONEOK, Inc. (OKE) and Pfizer Inc. (PFE) have volatilities of 6.90% and 6.60%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


4.00%5.00%6.00%7.00%8.00%9.00%10.00%AugustSeptemberOctoberNovemberDecember2025
6.90%
6.60%
OKE
PFE

Financials

OKE vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between ONEOK, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab